** Jefferies analysts maintain "buy" rating on Australia's ALS Ltd ALQ.AX at a price target of A$18.80 per share
** The testing services provider will report its FY25 results on May 27
** According to Jefferies, ALQ's biggest delta, minerals, has had a negative sample volume growth, which has been a drag for the company in most of FY24 and FY25
** At the April 28 trading update, we got confirmation that this has flipped to being a positive driver — Jefferies
** Brokerage says there should be few surprises in the FY results; sees promising signs for medium-term growth
** Stock has risen 17.6% this year, as of last close
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。